L'Oreal S.A.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
L'Oreal S.A. - overview
Established
1851
Location
Paris, -, France
Primary Industry
Consumer Products
About
L'Oreal S. A. , based in France, is a global cosmetics company specializing in beauty products, including makeup, skincare, haircare, and fragrances, committed to enhancing consumer beauty and well-being. Founded in 1909 by Eugène Schueller in Paris, France, L'Oreal S.
A. has grown into a multinational corporation that offers a wide range of beauty products. The company has continuously evolved its business strategies to cater to changing market demands, including expanding its presence in various global markets. L'Oreal is headquartered in Clichy, a suburb of Paris, and has numerous subsidiaries worldwide, reflecting its extensive operational footprint in the beauty industry.
L'Oreal is a global leader in the beauty industry, offering a diverse range of products spanning makeup, skincare, haircare, and fragrances. The company’s core offerings include consumer products such as L'Oréal Paris and Garnier, luxury brands like Lancôme and Yves Saint Laurent, and professional lines including L'Oréal Professionnel and Kérastase. Each product is designed to address specific consumer needs, from enhancing beauty to providing effective skincare solutions. L’Oreal's innovative approach includes utilizing advanced research and technology to develop high-quality and safe products that cater to the beauty aspirations of both women and men.
The company operates in numerous markets worldwide, including North America, Europe, Asia Pacific, and Africa, ensuring that its extensive portfolio reaches a wide and varied customer base that includes retail consumers, beauty professionals, and business partners. In the most recent financial year of 2024, L'Oreal reported a revenue of USD 47,062. 55 mn and an EBITDA of USD 10,936. 00 mn.
The company's revenue generation is supported through a multi-faceted transaction structure that includes direct sales to consumers, partnerships with retailers, and collaborations with beauty professionals. L’Oreal's pricing strategy varies across its product lines, reflecting the premium nature of its luxury brands compared to its mass-market offerings, contributing to its financial stability and growth potential. L'Oreal plans to introduce several new products in the coming years, targeting emerging trends in sustainable beauty and skincare innovation. The company is focusing on expanding its presence in Asia and Africa, aiming for a significant market share by 2025.
Recent funding will support these initiatives, particularly in product development and market entry strategies, ensuring that L'Oreal remains at the forefront of the global beauty landscape.
Primary Industry
Consumer Products
Sub Industries
Beauty & Hygiene
Website
http://www.loreal.com
Verticals
Manufacturing
Total Amount Raised
Subscriber access only
L'Oreal S.A. - timeline of key events
L'Oreal S.A. - financials
| Fiscal Year Ended | Dec 31, 2011 | Dec 31, 2012 | Dec 31, 2013 | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 20,343,100,000 | 22,462,700,000 | 22,976,600,000 | 22,532,000,000 | 25,257,400,000 | 25,837,100,000 | 26,023,700,000 | 26,937,400,000 | 29,873,600,000 | 27,992,100,000 | 32,287,600,000 | - | - | - |
| % Revenue Growth (YoY) | - | 10.4% | 2.3% | (1.9%) | 12.1% | 2.3% | 0.7% | 3.5% | 10.9% | (6.3%) | 15.3% | - | - | - |
| EBITDA (USD) | 3,810,600,000 | 4,265,100,000 | 4,579,700,000 | 4,439,700,000 | 5,128,100,000 | 5,420,600,000 | 5,618,500,000 | 5,936,600,000 | 6,714,300,000 | 6,528,100,000 | 7,509,300,000 | - | - | - |
| Operating Income (USD) | 3,196,300,000 | 3,573,500,000 | 3,739,600,000 | 3,583,500,000 | 4,194,300,000 | 3,996,100,000 | 4,400,000,000 | 4,827,300,000 | 5,111,000,000 | 4,500,000,000 | 5,728,300,000 | - | - | - |
| Operating Margin | 15.7% | 15.9% | 16.3% | 15.9% | 16.6% | 15.5% | 16.9% | 17.9% | 17.1% | 16.1% | 17.7% | - | - | - |
| % EBITDA Margin | 18.7% | 19.0% | 19.9% | 19.7% | 20.3% | 21.0% | 21.6% | 22.0% | 22.5% | 23.3% | 23.3% | - | - | - |
| NET Income (USD) | 2,440,900,000 | 2,870,400,000 | 2,961,400,000 | 4,908,600,000 | 3,298,500,000 | 3,108,700,000 | 3,585,500,000 | 3,899,500,000 | 3,755,200,000 | 3,567,600,000 | 4,602,200,000 | - | - | - |
| % Net Margin | 12.0% | 12.8% | 12.9% | 21.8% | 13.1% | 12.0% | 13.8% | 14.5% | 12.6% | 12.7% | 14.3% | - | - | - |
L'Oreal S.A. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Trade Sale | Announced | Medik8 Limited | - | ||||||||
| Trade Sale | Completed | Galderma | - | ||||||||
| Corporate Carve Out | Completed | Sanoflore Laboratories | - | ||||||||
| Trade Sale | Completed | Youth to the People Inc. | - | ||||||||
| Trade Sale | Completed | IT Cosmetics, LLC | - |
Displaying 1 - 5 of 10
L'Oreal S.A. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.